Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5
Methods Women 'randomly allocated' to 2 groups. A random number table used to generate the allocation sequence and allocation was done by sealed envelopes. Placebos were not used. Side effects were recorded by women
Participants 880 healthy women attending Family Planning Association clinics in Hong Kong
Included women with regular menstrual periods (21‐35 days), aged 18‐45 years, with a single act of unprotected intercourse within 48 h of attending the clinic
Interventions Yuzpe (ethinyl oestradiol 100 μg + norgestrel 1 mg, repeated after 12 h) vs LNG 0.75 mg, orally, 2 doses 12 h apart
Outcomes Observed number of pregnancies, side effects and changes in menstrual pattern
Notes
  1. Observed pregnancy/expected pregnancy/total number of women: Yuzpe 15/22/424; LNG 12/20/410

  2. Loss to follow‐up: Yuzpe 16/440 (3.6%); LNG 30/440 (6.8%)

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Women were 'randomly allocated' into 2 groups ‐ doesn't state how
Allocation concealment (selection bias) Unclear risk Method of concealment not stated
Blinding (performance bias and detection bias) All outcomes Unclear risk Blinding not stated
Incomplete outcome data (attrition bias) All outcomes Low risk Reported loss to follow‐up‐ "Of these, 16 subjects in the Yuzpe group and 30 subjects in the levonorgestrel group were lost to follow up after the first visit and the results of treatment were not known. These subjects were excluded from the analysis."
Selective reporting (reporting bias) Low risk Planned outcomes were reported
Other bias Low risk None detected